Last updated on: 4/6/2011 | Author:

Anthony Feinstein, PhD, MD Biography

Professor of Psychiatry at the University of Toronto
Not Clearly Pro or Con to the question "Should Marijuana Be a Medical Option?"

“I would stop and think very carefully about cannabis use… it concerns me that there’s a movement that cannabis can be [viewed] as a benign drug. So I would want to look at cannabis very closely before using it. The database is still small… there are so many unanswered questions.”

Maureen Salamon, “Medical Marijuana Might Slow Thinking Among MS Patients,”, Mar. 28, 2011

[Editor’s Note: The original quote in the Mar. 28, 2011 article stated “it concerns me that there’s a movement that cannabis can be used as a benign drug.” When sent this biography to Dr. Feinstein to confirm its accuracy on Mar. 31, 2011, he noted that “viewed” is a better word than “used” and asked us to change it from the original quote reported on]

Involvement and Affiliations:
  • Professor of Psychiatry, University of Toronto
  • Director, Canadian Journalism Forum on Violence and Trauma, 2010-present
  • Director, Neuropsychiatry Programme, Sunnybrook and Women’s College Health Sciences Centre
  • Associate Scientist, Sunnybrook Research Institute
  • Member, Advisory Council, Dart Center for Journalism and Trauma
  • Recipient, Guggenheim Fellowship, 2000-2001
  • Fellow of the Royal College of Physicians of Canada (FRCPC), 1996
  • Member of the Royal College of Psychiatrists (MRCPsych), 1988
  • PhD, University of London, 1992
  • Master of Philosophy, University of London, 1990
  • MD, University of the Witwatersrand (South Africa), 1980
  • Completed training as a neuropsychiatrist at the University College London Institute of Neurology, Queen Square (London, England)
  • Completed training in psychiatry at the Royal Free Hospital (London, England)